Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax compared with Turbuhaler in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain

All of RECERCAT

To access the full text documents, please follow this link: http://hdl.handle.net/2445/107750

Title:	Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax compared with Turbuhaler in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain
Author:	Darbà, Josep; Ramírez, Gabriela; García-Rivero, Juan L.; Mayoralas, Sagrario; Pascual, José Francisco; Vargas, Diego; Bijedic, Adi
Other authors:	Universitat de Barcelona
Abstract:	The objective of this study was to estimate the economic impact of the introduction of DuoResp® Spiromax®, budesonide/formoterol fixed-dose combination (FDC), focusing on an increase in medication adherence due to an enhancement of the inhalation technique for the treatment of COPD patients in Spain and 5 regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia. ...
Subject(s):	-Administració de medicaments -Malalties pulmonars obstructives cròniques -Tractament tèrmic -Economia de la salut -Administration of drugs -Chronic obstructive pulmonary diseases -Heat treatment -Medical economics
Rights:	cc-by-nc (c) Darbà, Josep et al., 2017 http://creativecommons.org/licenses/by-nc/3.0/es
Document type:	Article Article - Published version
Published by:	Dove Medical Press
Share: